Journal of magnetic resonance imaging : JMRI
33619859
BACKGROUND: Contrast-enhanced magnetic resonance angiography (MRA) is used to assess various cardiovascular conditions. However, gadolinium-based contrast agents (GBCAs) carry a risk of dose-related adverse effects.